Effect of Self-administered tDCS in Patients With MDD
Status:
Completed
Trial end date:
2019-05-02
Target enrollment:
Participant gender:
Summary
In this randomized, single-blinded clinical trial, 58 patients with major depressive disorder
were assigned to active and sham tDCS stimulation groups in a 1:1 ratio, and treatment
responses were evaluated biweekly over six weeks.